Gene Therapy

Gene Therapy includes companies delivering genetic material to correct, replace, silence, or modulate disease-driving biology. This sector page is useful for following businesses exposed to AAV, lentiviral, non-viral, or editing-enabled approaches across rare and broader diseases.

Why watch Gene Therapy

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Gene Therapy news

The latest feed items from companies currently grouped under Gene Therapy.

1. 01
   2026-10-07 13:36 EST

   RCKTRocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar

   Source: Rocket Pharmaceuticals

2. 02
   2026-10-06 20:12 EST

   RCKTRocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital

   Source: Rocket Pharmaceuticals

3. 03
   2026-10-06 20:05 EST

   CRBUCaribou Biosciences to Evaluate Strategic Alternatives

   Source: Caribou

4. 04
   2026-10-06 14:00 EST

   GSKViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia

   Source: GSK plc

5. 05
   2026-10-06 11:02 EST

   OCGNOcugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate

   Source: Ocugen

6. 06
   2026-10-06 05:30 EST

   SNYCommuniqué de presse : Mise en ligne du document «Q3 2026 aide-mémoire »

   Source: Sanofi

7. 07
   2026-10-06 05:30 EST

   SNYPress Release : Availability of the aide-mémoire for Q3 2026 results

   Source: Sanofi

8. 08
   2026-10-02 20:01 EST

   NTLAIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: Intellia

9. 09
   2026-10-02 20:01 EST

   NTLAIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: Intellia

10. 10
    2026-10-02 14:15 EST

    CRSPCRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026

    Source: CRISPR Therapeutics

11. 11
    2026-10-02 12:00 EST

    TSHATaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Source: Taysha Gene Therapies

12. 12
    2026-10-02 11:30 EST

    ABEOAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Abeona Therapeutics

13. 13
    2026-10-01 12:00 EST

    TSHATaysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting

    Source: Taysha Gene Therapies

14. 14
    2026-10-01 06:00 EST

    RHHBYRoche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions

    Source: Roche Holdings AG

15. 15
    2026-10-01 05:00 EST

    SNYCommuniqué de presse : Sanofi et Regeneron élargissent leur Alliance mondiale avec plusieurs anticorps immunologiques de nouvelle génération à action prolongée

    Source: Sanofi

16. 16
    2026-10-01 05:00 EST

    SNYPress Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

    Source: Sanofi

17. 17
    2026-10-01 05:00 EST

    RHHBYRoche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine

    Source: Roche Holdings AG

18. 18
    2026-09-30 20:30 EST

    SRPTSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Sarepta Therapeutics

19. 19
    2026-09-30 12:30 EST

    SRPTSarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Older Ambulatory Patients with Duchenne

    Source: Sarepta Therapeutics

20. 20
    2026-09-30 11:02 EST

    OCGNOcugen to Participate in Upcoming Scientific Conferences

    Source: Ocugen

Companies in Gene Therapy

37 companies tagged with Gene Therapy.

Frequently Asked Questions